NVO
Novo Nordisk A/S$43.55
LiveJun 16, 2026
Market cap
$193.53B
52w range
35.12 – 75.78
P / E
—
EPS
—
Volume
6.49M
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Novo Nordisk A/S’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $45.00 (+3.33%)
Candlestick · 1Y
Open in chart workstation →NVO
43.92-42.98%H 78.38L 35.12MA50 42.47MA200 48.42Avg vol 18.2M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.84% | +1.35% | -2.66% | +12.88% | -11.05% | -14.41% | -43.46% | -46.00% | +4.14% | +68.93% | +27118.75% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$43.58
1,943 sh
Bid
$43.48
400 sh
Ask
$43.50
500 sh
Spread
$0.020
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Energy+0.42%
- Consumer Cyclical+0.27%
- Basic Materials+0.27%
- Industrials+0.22%
- Consumer Defensive+0.09%
- Real Estate-0.34%
- Financial Services-0.45%
- Utilities-0.49%
- Healthcare-0.92%
- Communication Services-1.12%
- Technology-2.11%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-1.17%
- Electronic Gaming & Multimedia+7.50%
- Biotechnology-3.87%
- Hardware, Equipment & Parts-3.62%
- Communication Equipment-3.51%
- Department Stores-2.85%
- Medical - Equipment & Services+2.65%
- Apparel - Manufacturers-2.63%
- Independent Power Producers+2.40%
- Semiconductors-2.37%
- Trucking-2.33%
- Oil & Gas Drilling-2.15%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$45.00
+3.48% upside
Low
$45.00
Median
$45.00
High
$45.00
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Novo Nordisk to File Oral Wegovy in Chinagurufocus.com·Jun 16, 2026
- Hacking group claims major hack of Novo Nordisk and attempted $25 million extortionreuters.com·Jun 16, 2026
- Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Knowzacks.com·Jun 16, 2026
- Novo Nordisk: I Was Fooled By The Market Again (Rating Upgrade)seekingalpha.com·Jun 16, 2026
- Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEOreuters.com·Jun 16, 2026
- Novo Nordisk Gains 7% in a Week: How Should Investors Play the Stock?zacks.com·Jun 15, 2026
- NVO DCF Analysis: Intrinsic Value $90 vs Price $44gurufocus.com·Jun 15, 2026
- Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry Aboutfool.com·Jun 12, 2026
Peers
No peer list available for NVO.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|